Selection of endpoints for clinical trials of acute renal failure in critically ill patients

Current Opinion in Critical Care

Volumn 8, Issue 6, 2002, Pages 515-518

  Palevsky, Paul M ^a   Metnitz, Philipp G H ^b   Piccinni, Pasquale ^c   Vinsonneau, Christophe ^d  

^a Vetr Aff Pittsburgh Hlthcare Sys   (United States)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c SAN BORTOLO HOSPITAL   (Italy)

^d Hôpital Cochin ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONFERENCE PAPER; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; FUNCTIONAL ASSESSMENT; HUMAN; HYPOTHESIS; ITALY; KIDNEY FUNCTION; METHODOLOGY; MORTALITY; OUTCOMES RESEARCH;

CLINICAL TRIALS; COSTS AND COST ANALYSIS; ENDPOINT DETERMINATION; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MORBIDITY; SURVIVAL ANALYSIS;

EID: 0036892451     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075198-200212000-00006     Document Type: Conference Paper

References (26)

1. Schiffl H, Lang SM, König A, et al.: Biocompatible membranes in acute renal failure: Prospective case-controlled study. Lancet 1994, 344:570-572.
2. Himmelfarb J, Tolkoff-Rubin N, Chandran P, et al.: A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998, 9:257-266.
3. Ronco C, Bellomo R, Homel P, et al.: Effects of different doses on continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000, 356:26-30. The only randomized controlled trial comparing three doses of continuous venovenous hemofiltration in patients with ARF. This study demonstrated an improved survival rate when continuous venovenous hemofiltration was dosed to provide at least 35 mL/kg/h of ultrafiltration as compared with 20 mg/kg/h. The primary endpoint in this study was survival 15 days after discontinuation of treatment.
4. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002, 346:305-310. The largest trial comparing daily intermittent hemodialysis to every-other-day intermittent hemodialysis in patients with ARF. The study, which had alternating patient assignment, reported a reduction in mortality from 46% with alternate-day hemodialysis to 28% with daily hemodialysis. The primary endpoint was survival 14 days after the last hemodialysis treatment.
5. Mehta RL, McDonald B, Gabbal FB, et al.: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001, 60:1154-1163. A large, randomized, controlled trial comparing continuous renal replacement therapy with intermittent hemodialysis. This study was flawed by imbalanced randomization, which resulted in a greater severity of illness in patients in the continuous renal replacement therapy group. The primary outcome measure was all-cause ICU mortality. A higher mortality rate was observed in the continuous renal replacement therapy group as compared with the intermittent hemodialysis group.
6. Hébert PC, Cook DJ, Wells G, et al.: The design of randomized clinical trials in critically ill patients. Chest 2002, 121:1290-1300. A critical review of design issues for randomized, controlled trials involving critically ill patients.
7. Capuzzo M, Valpondi V, Zardi S, et al.: Mortality of intensive care patients: At a fixed point in time or in the hospital [abstract]? Intensive Care Med 2001, 27(suppl 2):A367.
8. Gastaldello K, Melot C, Kahn RJ, et al.: Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant 2000, 15:224-230.
9. Goris RJ, te Boekhorst TP, Nuytinck JK, et al.: Multiple-organ failure. Generalized autodestructive inflammation? Arch Surg 1985, 120:1109-1115.
10. Tran DD, Groeneveld ABJ, Van der Meulen J, et al.: Age, chronic disease, sepsis, organ system failure and mortality in a medical intensive care unit. Crit Care Med 1990, 18:474-479.
11. Marshall JC, Cook DJ, Christou V, et al.: Multiple Organ Dysfunction Score: A reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652.
12. Vincent JL, Mendonca A, Cantraine F, et al.: Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Crit Care Med 1998, 26:1793-1800.
13. Le Gall JR, Klar J, Lemeshow S, et al.: The logistic organ dysfunction system. A new way to assess organ dysfunction in the intensive care unit. JAMA 1996, 276:802-810.
14. De Mendonca A, Vincent JL, Suter PM, et al.: Acute renal failure in the ICU: Risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000, 26:915-921.
15. Le Gall JR, Lemeshow S, Saulnier F: A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
16. Knaus WA, Draper EA, Wagner DP, et al.: APACHE II: A severity of disease classification system. Crit Care Med 1985, 13:818-829.
17. Gyldmark M: A review of cost studies of intensive care units: Problems with the cost concept. Crit Care Med 1995, 23:964-972.
18. Hamel MB, Phillips RS, Davis RB, et al.: Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. Ann Intern Med 1997, 127:195-202.
19. Korkeila M, Ruokonen E, Takala J: Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000, 26:1824-1831.
20. Reeves JH, Cumming AR, Gallagher L, et al.: A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 1999, 27:2316-2317.
21. Ash SR, Bever SL: Peritoneal dialysis for acute renal failure: The safe, effective, and low-cost modality. Adv Ren Replace Ther 1995, 2:160-163.
22. Reznik VM, Randolph G, Collins CM, et al.: Cost analysis of dialysis modalities for pediatric acute renal failure. Perit Dial Int 1993, 13:311-313.
23. Cullen DJ, Civetta JM, Briggs BA, et al.: The Therapeutic Intervention Scoring System: A method for quantitative comparison of patient care. Crit Care Med 1975, 3:222-225.
24. Miranda DR, De Rijk A, Schaufeli W: Simplified Therapeutic Interventions Scoring System: The TISS-28 items-results from a multicenter study. Crit Care Med 1996, 24:64-73.
25. Dickie H, Vedio A, Dundas R, et al.: Relationship between TISS and ICU cost. Intensive Care Med 1998, 24:1009-1017.
26. Miranda DR: Outcome assessment-TISS as a tool to evaluate cost-effectiveness of immunological treatment. Eur J Surg Suppl 1999, 584:51-55.